Education
About Us
Working with TipRanks
Follow Us
Brooks Laboratories Limited (IN:BROOKS)
:BROOKS
RESEARCH TOOLSreports
Total Valuation
Brooks Laboratories Limited has a market cap or net worth of ₹4.26B. The enterprise value is ₹3.98B.
Market Cap₹4.26B
Enterprise Value₹3.98B
Share Statistics
Brooks Laboratories Limited has 29,457,249 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,457,249
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Brooks Laboratories Limited’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is 3.17%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)3.17%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee2.82M
Profits Per Employee-340.17K
Employee Count293
Asset Turnover0.67
Inventory Turnover7.46
Valuation Ratios
The current PE Ratio of Brooks Laboratories Limited is 348.0. Brooks Laboratories Limited’s PEG ratio is ―.
PE Ratio348.0
PS Ratio―
PB Ratio―
Price to Fair Value3.42
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Brooks Laboratories Limited had revenue of 825.57M and earned -99.67M in profits. Earnings per share was -3.29.
Revenue825.57M
Gross Profit139.22M
Operating Income33.37M
Pretax Income-97.92M
Net Income-99.67M
EBITDA58.22M
Earnings Per Share (EPS)-3.29
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Brooks Laboratories Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.34
52-Week Price Change12.90%
50-Day Moving Average149.47
200-Day Moving Average142.69
Relative Strength Index (RSI)56.17
Average Volume (3m)3.44K
Important Dates
Brooks Laboratories Limited upcoming earnings date is Nov 7, 2025, TBA (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 7, 2025
Ex-Dividend Date―
Financial Position
Brooks Laboratories Limited as a current ratio of 1.48, with Debt / Equity ratio of 7.73%
Current Ratio1.48
Quick Ratio1.08
Debt to Market Cap0.02
Net Debt to EBITDA1.09
Interest Coverage Ratio3.25
Taxes
In the past 12 months, Brooks Laboratories Limited has paid 1.75M in taxes.
Income Tax1.75M
Effective Tax Rate-0.02
Enterprise Valuation
Brooks Laboratories Limited EV to EBITDA ratio is 58.68, with an EV/FCF ratio of -3.52K.
EV to Sales4.14
EV to EBITDA58.68
EV to Free Cash Flow-3.52K
EV to Operating Cash Flow193.85
Balance Sheet
Brooks Laboratories Limited has ₹8.08M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹8.08M billion.
Cash & Marketable Securities₹8.08M
Total Debt₹0.00
Net Cash-₹8.08M
Net Cash Per Share-₹0.27
Tangible Book Value Per Share₹32.40
Margins
Gross margin is 31.77%, with operating margin of 4.04%, and net profit margin of -12.07%.
Gross Margin31.77%
Operating Margin4.04%
Pretax Margin-11.86%
Net Profit Margin-12.07%
EBITDA Margin7.05%
EBIT Margin5.11%
Analyst Forecast
The average price target for Brooks Laboratories Limited is ₹141.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹141.00
Price Target Upside-7.15% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast10.30%
EPS Growth Forecast―